Advanced Analytics

Parallel Trade Management

Impact assessment and strategy

Alira Health provides pharmaceutical and medical device companies support in assessing the impact of parallel trade on their financial performance and reputation.
We take a quantitative approach that aims to reconstruct parallel export flows at the European level. This identifies and prioritizes the markets where we may need to redefine distribution strategy and commercial agreements.

Together, we’ll work closely to design effective launch strategies aimed at managing parallel trade at the local and corporate level.

In-house training and support

We can also provide solutions designed to increase internal awareness and support sustainable performance management. Our approach includes training operational teams and consolidating reference data sources to EU-level value generation rather than country-specific volumes.

A global team of trade and data experts

When you partner with Alira Health, you gain access to a global team of data and parallel trade experts with over 15 years of pharmaceutical and medical device industry experience.

Together, we’ll build data-driven, comprehensive strategies designed to empower your company’s tools and capabilities.

Related News

Events September 30, 2022
XV Congresso Nazionale Sihta
We are pleased to share that we will be joining as speakers and sponsors XV Congresso Nazionale Sihta, a key event for Italian Healthcare industry.
Digital Health Real-World Evidence
Multimedia September 29, 2022
Regulatory Strategy for Registering Rare Disease Products in the EU
In this webinar we will focus on how to benefit, today and in the future, from the orphan drug program and build a regulatory strategy for successful rare disease product registration(...)
Drug Development Rare Disease Regulatory
News September 27, 2022
AseBio and Alira Health Partner to Foster Market Access for Biotech Startups
Alira Health and AseBio, the Spanish Bioindustry Association, are joining forces to support Spanish biotech companies looking to enter new markets.
Biotech Market Access Startups
Events September 20, 2022
Outsourcing in Clinical Trials New England 2022
We are excited to share that we will be attending and exhibiting at Outsourcing in Clinical Trials New England in Boston.
Clinical Operations Clinical Trials Healthcare Technology Hybrid Clinical Trials Rare Disease Trials
Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 14, 2022
Critical Quality Attributes for Drug Products
In this article, we will explore the importance of Critical Quality Attributes (CQAs) in the drug development lifecycle and why it is vital that your selected CDMO is capable of addressing them.
Biotech CDMO Drug Development
Publications September 8, 2022
Best Practices in the CDMO Selection Process
The CDMO series provides sound advice to agile biotech companies in identifying and selecting the right Contract Development and Manufacturing Organization (CDMO) for advancing the(...)
CDMO
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.